1,907 matches
-
of Psychiatry (2nd. ed.Ă. Washington, DC: American Psychiatric Press, Inc. Holmes, E. A., Brown, R. J., Mansell, W., Pasco Fearon, R., Hunter, E. C. M., Frasquilho, F. & Oakley, D. A. (2005Ă. Are there two qualitatively distinct forms of dissociation? A review and some clinical implications. Clinical Psychology Review, 25, 1-23. Holmes, T. H. & Rahe, R. H. (1967Ă. The social readjustment rating scale. Journal of Psychosomatic Research, 11, 213-218. House of Lords Select Committee. Select Committee on Science and Technology: Sixth Report. 21-11-2000. Howsam
[Corola-publishinghouse/Science/2003_a_3328]
-
life and survival. Contemporary Hypnosis, 15(1Ă, 34-38. Walker, L. G. (2004Ă. Hypnotherapeutic insights and interventions: A cancer odyssey. Contemporary Hypnosis, 21(1Ă. Walker, L. G., Dawson, A. A., Lolley, J. & Ratcliffe, M. A. (1988bă. Sick to death of it: some psychological aspects of chemotherapy side effects. Aberdeen Postgraduate Medical Bulletin, 22, 11-17. Walker, L. G., Heys, S. D., Walker, M. B., Ogston, I. D., Hutcheon, A. W., Starker, T. K., Ah-See, A. K. & Eremin, O. (1999Ă. Psychological factors can predict the response
[Corola-publishinghouse/Science/2003_a_3328]
-
euro-americană: Tolstoy or Dostoievsky/Tolstoi sau Dostoievski (1958), o monografie critică întrucîtva comparativă asupra celor doi romancieri ruși, The Death of Tragedy/Moartea tragediei (1961), o replică teoretică dată filozofiei asupra tragicului, articulate anterior de către Nietzsche, In Bluebeard's Castle: Some Notes Towards the Redefinition of Culture/În castelul lui Barbă Albastră: cîteva note referitoare la redefinirea culturii (1971), o contribuție importantă la impunerea studiilor culturale ca metodologie critică perfect acceptabilă pentru rigorile "canonice" ale modernității tîrzii și foarte cunoscuta After
[Corola-publishinghouse/Science/1479_a_2777]
-
fewer women have published personal research and annual funding level was lower than that achieved by men working în the same research environments. This paper present an analysis of the current representation of women în academic and scientific research, and some models currently available at European and global level, în order to be more promoted în scientific research, according to political and economic realities. The issues are presented emerging from the particularities of the medical field that blends clinical care with
[Corola-publishinghouse/Science/84980_a_85765]
-
foreign policy, at the beginning of XXIst century, develops a multitude of complex political concepts, such aș harmonious world, the Five Principles of Peaceful Co-existence, New Relations between Great Powers, Peaceful Rise of Chină and others. The paper explores only some dimensions of two political concepts, such aș the New Chinese Security concept and the Peaceful Rise of Chină, by revealing the contemporary meanings if these concepts and also, by emphasizing their roots within the philosophical ancient visions of the Chinese
[Corola-publishinghouse/Science/84980_a_85765]
-
în Sun Zi's Art of War, a 2500-old text, aș the "buzhan ersheng" strategy, "the art of winning without fighting 52"), connected to the political theory of the "window of opportunity" open for Chină în the contemporary internațional relations. Some conclusions The complex concept of Peaceful Assertion/Rising of Chină includes more and more the proactive cultural component (foundation of Confucius institutes, of centres teaching Chinese, familiarization of partners of Chinese corporations with the cultural values of Chină, intensification of
[Corola-publishinghouse/Science/84980_a_85765]
-
development of women with higher education, with applications în academic and research work în the medical field. The author is also associate professor at the University of Medicine and Pharmacy "Grigore Ț. Popa" - Iași; she published books, chapters and articles, some of them having connection with the humanistic and sociological field ("Religion and medicine or the spiritual dimension of healing", Journal for the study of religions and ideologies 2012; "Current perspectives în stress research and cardiometabolic risk", Revista de cercetare și
[Corola-publishinghouse/Science/84980_a_85765]
-
Gabowski, Antoine Bechara, Hanna Damasio, Laura L.B. Ponto, Josef Parvisi și Richard D. Hichwa, „Subcortical and Cortical Brain Activity during the Feeling of Self Generated Emotions”, Nature Neuroscience, nr. 3, 2000, pp. 1049-1056. Jones N.G. Blurton, „An Ethological Study of Some Aspects of Social Behaviour of Children in Nursery Schools”, în Primate Ethology, de D. Morris, Weidenfeld și Nicholson, Londra, 1967, pp. 347-368. Hubert Montagner, op. cit. , p. 95. Siegfried Frey, Hans-Peter Hirsbrunner, Anne-Marie Florin, Walid Daw și Obsert Crawford, „Analyse intégrée
[Corola-publishinghouse/Science/2336_a_3661]
-
în jurul canonului, europocentrist, prezentă aici prin eseul lui Mircea Martin), este privit din afară. Europa este, la origine, o colonie, "the first great colony of the world, at least of the Western world", cu un extraordinar destin, dar și, probabil "some inbuilt psychological insecurity" care o fac ostilă față de Celălalt (fie el evreu, asiatic, african sau american) și chiar față de jumătatea sa estică. în același timp, însă, beneficiind de un anume "pluri-centrism, a multiplication of layers, a diversity of angles and
Identificări by Roxana Racaru () [Corola-journal/Journalistic/15639_a_16964]
-
the căușe and kill facebook for the sake of your own privacy. Facebook has been selling information to government agencies and giving clandestine access to information security firms șo that they can spy on people from all around the world. Some of these so-called whitehat infosec firms are working for authoritarian governments, such aș those of Egypt and Syria. Everything you do on Facebook stays on Facebook regardless of your “privacy” settings, and deleting your account is impossible, even if you
Va dispărea Facebook, sâmbătă, 5 noiembrie? Vezi aici mesajul hackerilor de la Anonymous () [Corola-journal/Journalistic/68407_a_69732]
-
adresa astfel: "To Professor and Justice Felix Frankfurter, aș a sincere taken of high and respectfull appreciation for hîș educațional methods and for hîș creative personality. This book, written by a Romanian who got hîș Ph.D. în U.S.A. some years ago, mentions your activity and personality at the pp. 360-362 and 411. It is my third book on America published since 1933. It tries to stress upon all the creative ideas, facts and attitudes of your civilization, în order
Petru Comarnescu și S. U. A. by Icu Crăciun () [Corola-journal/Journalistic/8035_a_9360]
-
în Occident, la cel mai înalt nivel. Câți dintre detractorii săi vor avea măcar o dată în viață o recenzie în „Times Literary Supplement”, „Foreign Affairs”, „Wall Street Journal” etc., etc., așa cum a avut The Devil in History. Communism, Fascism, and Some Lessons of the Twentieth Century, University of California Press, 2012)? Pot să spun: atunci când va scrie despre ei Vladimir Tismăneanu! Deși ofense imunde contra lui au existat încă din 1990, ele au devenit nemiloase, organizate militărește, începând cu 18 decembrie
Al treilea val by Mircea Mihăieș () [Corola-journal/Journalistic/3852_a_5177]
-
a more efficient management of existing funds. For six years, România hâș been removed from the map of medical innovation. Patients don’ț have access to pharmaceutical technology discoveries made after 2000. Even though there have been important discoveries în some therapeutic areas, they have not reached the Romanian patient. I asked Fabrizio Giombini, General Manager of MSD România how he sees the situation from the perspective of a major pharmaceutical company that invested în our country. The pharmaceutical industry în
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
the last six years.. This means that the Romanian patients have not benefited from the innovative therapies discovered în the last period of time, although other European countries have reimbursed a large amount of these medicines. The recent reimbursement of some orphan drugs is the only positive sign în the last six years, referring strictly to the list of reimbursement drugs. Aș you know, at the moment, a new methodology for evaluating the molecules is în evaluation process. The pharmaceutical industry
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
solution to implement this new methodology. We are confident that the situation will unlock, and that the authorities will implement a new list of reimbursed medicines starting this autumn, aș per their official statements Can we talk about unfair competition? Some companies have new drugs on the reimbursement list, others didn’ț hâd this chance for long time. Indeed, în the first half of 2014 the reimbursed medicines list hâș been updated with some important orphan therapies. This is extremely important
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
statements Can we talk about unfair competition? Some companies have new drugs on the reimbursement list, others didn’ț hâd this chance for long time. Indeed, în the first half of 2014 the reimbursed medicines list hâș been updated with some important orphan therapies. This is extremely important for the Romanian patients who need these therapies and it is also a positive signal from the authorities, if we think that în the last six years there hâș not been any updates
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
is also a positive signal from the authorities, if we think that în the last six years there hâș not been any updates to the list. However, the lack of reimbursement of other important molecules gives uș the risk that some products registered 3-4 years ago, aș new drugs, innovative, to become "old" and the products of the competition that entered the market later to be promoted. Artificial blockages distort the market. But the main problems concerns the Romanian patients, that
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
by the Romanian authorities might help them improve their health and even save their lives. For Example? For example, MSD registered în România a new drug for hepatitis C that not only treat, but even cures the disease permanently, în some categories of patients. It is the last hope for patients who have not responded positively to the therapies currently available în România. For them it is a matter of life and death and every waiting day costs them months of
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
widely used, but only for certain categories of patients. The new list would generate a moderate growth for the pharmaceutical industry în România, but what is the most important thing is that the patient will have access to new therapies. Some companies have limited operations în România. Is there a risk for companies to leave the Romanian market? Indeed, this risk exists. There are situations where pharmaceutical companies don’ț have any more local management, being managed by regional teams. What
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
în partnership with the Government. Provided that the authorities not to see the healthcare aș a cost or aș an extra expense but aș an opportunity to rapidly improve the quality of life în România. It is essential to have some minimum conditions to operate în this market aș to provide the best innovative solutions to the Romanian patients. How is the Romanian market compared to that of your native country, Italy? There are some similarities. Before coming to România, I
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
România. It is essential to have some minimum conditions to operate în this market aș to provide the best innovative solutions to the Romanian patients. How is the Romanian market compared to that of your native country, Italy? There are some similarities. Before coming to România, I thought that Italy was one of the most difficult countries în terms of market access policies. I hâd to admit that România is also a challenging environment. Italy also confronts with cost containment measures
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
waiting to be included în the reimbursement list. A innovative product for the treatment of hepatitis C, one used în the diabetes therapy, one în autoimmune diseases and another one, în oncology. Also, MSD researchers are advancing their work on some important products against HIV, a new class of anti-AIDS, anti-diabetes medicines and also a new generation of dugs addressing the Alzheimer disease. În addition, MSD laboratories are rapidly advancing the research regarding a new generation of products for the treatment
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
other European countries. We cannot talk about improving health services, without improving the patient access to innovative therapies. Do generic medicines represent a solution? We often hear this question: are generics important? Yes, they are important. Besides their medical importance, some countries encourage the use of generic drugs to reduce costs. Nevertheless according to some European studies, România is one of the European countries that hâș a high level of generics use and consumption of generic drugs.
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
access to innovative therapies. Do generic medicines represent a solution? We often hear this question: are generics important? Yes, they are important. Besides their medical importance, some countries encourage the use of generic drugs to reduce costs. Nevertheless according to some European studies, România is one of the European countries that hâș a high level of generics use and consumption of generic drugs.
Interview with general manager Merck Sharp and Dohme Romania - Fabrizio Giombini () [Corola-journal/Journalistic/77335_a_78660]
-
permite să urmărim paralelismele evoluțiilor lingvistice recente, trebuie să observăm, în treacăt, o formă telectual și în engleză: o creație ad-hoc, în textul unei melodii al unei formații rock, vizînd probabil și un joc de cuvinte, o aluzie la televiziune: ,some kind of telectual" (TV Pro, cf. lyricscafe.com); evident, tradus în franceză, respectivul text conține forma telectuel (lacoccinelle.net) ! Revenind la română, constatăm că ironia se exercită asupra cuvîntului intelectual și în alte moduri: prin introducere în contextele pragmatice de
Telectuali by Rodica Zafiu () [Corola-journal/Journalistic/12492_a_13817]